LY518674
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY518674, covering 2015-12-11 to 2015-12-11. Get the full timeline:
Most recent: Clinical Trial Update: A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism [Phase 2]